Early continuous hypertonic saline infusion in patients with severe cerebrovascular disease

被引:59
|
作者
Hauer, Eva-Maria [1 ]
Stark, David [1 ]
Staykov, Dimitre [1 ]
Steigleder, Tobias [1 ]
Schwab, Stefan [1 ]
Bardutzky, Juergen [2 ]
机构
[1] Univ Erlangen Nurnberg, Dept Neurol, Erlangen, Germany
[2] Univ Freiburg, Dept Neurol, D-7800 Freiburg, Germany
关键词
hypertonic saline; intracranial pressure; cerebral edema; osmotherapy; brain ischemia; intracerebral hemorrhage; subarachnoid hemorrhage; CEREBRAL-BLOOD-FLOW; INCREASED INTRACRANIAL-PRESSURE; SODIUM-CHLORIDE; 20-PERCENT MANNITOL; 7.5-PERCENT SALINE; LACTATED RINGERS; EDEMA; HYPERTENSION; THERAPY; TRIAL;
D O I
10.1097/CCM.0b013e318218a390
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: To study the safety and the effects of early continuous hypertonic saline infusion in patients with cerebral edema and underlying cerebrovascular disease. Design: Retrospective analysis. Setting: University medical center. Patients: Neurologic intensive care unit population with mixed cerebrovascular diseases. Interventions: None. Measurements and Main Results: Between May 2008 and December 2009, 100 patients with severe intracerebral hemorrhage, cerebral ischemia, or aneurysmal subarachnoid hemorrhage and signs of intracranial hypertension received within <= 72 hrs after symptom onset a continuous infusion of hypertonic saline (3%, target sodium 145-155 mmol/L, target osmolality 310-320 m0sm/kg) over 13 (4-23) days. We analyzed the frequency of episodes with elevated intracranial pressure (new anisocoria or intracranial pressure > 20 mm Hg for >= 20 mins), inhospital mortality, and the occurrence of adverse effects theoretically associated with hypertonic saline. The findings were compared with those of a historical control group (n = 115, 2007-2008) with equal underlying disease. In the treatment group, fewer episodes of critically elevated intracranial pressure (92 vs. 167, p =.027) in fewer patients (50 of 100 = 50.0% vs. 69 of 115 = 60.0% patients, p =.091) were observed, and inhospital mortality was significantly decreased (17.0% vs. 29.6%, p =.037). Adverse events, including cardiac arrhythmia, heart, liver or renal dysfunction, or pulmonary edema, occurred in both groups to a similar extent. Conclusions: Early and continuous infusion of hypertonic saline in patients with severe cerebrovascular disease and impending intracranial hypertension is safe and might reduce the frequency of intracranial pressure crises and mortality rate. A randomized controlled trial is warranted to confirm our findings and to evaluate the effects of hypertonic saline on functional outcomes. (Crit Care Med 2011; 39: 1766-1772)
引用
收藏
页码:1766 / 1772
页数:7
相关论文
共 50 条
  • [41] Effect of early hemorrhage control and hypertonic saline solution infusion on tissue perfusion and oxygenation indices
    Candido, M
    Poggetti, R
    Fontes, B
    Birolini, D
    PROCEEDINGS OF THE 6TH WORLD CONGRESS ON TRAUMA, SHOCK, INFLAMMATION AND SEPSIS- PATHOPHYSIOLOGY, IMMUNE CONSEQUENCES AND THERAPY, 2004, : 5 - 8
  • [42] Fluid overload during cardiopulmonary bypass is effectively reduced by a continuous infusion of hypertonic saline/dextran (HSD)
    Kvalheim, Venny L.
    Rynning, Stein E.
    Farstad, Marit
    Haugen, Oddbjorn
    Nygreen, Else
    Mongstad, Arve
    Husby, Paul
    SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2008, 42 (01) : 63 - 70
  • [43] CONTINUOUS INFUSION TREATMENT WITH PENTOXIFYLLINE IN PATIENTS WITH SEVERE PERIPHERAL VASCULAR OCCLUSIVE DISEASE
    ANGELIDES, NS
    ANGIOLOGY, 1986, 37 (08) : 555 - 564
  • [44] Inhaled 7% Hypertonic Saline Is Safe To Administer In Patients With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD)
    Cole, E.
    Boucher, R. C.
    Fuller, F.
    Henderson, A. G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [45] Protocol for Administration of Hypertonic Saline in Medical Intensive Care Patients With Severe Stroke
    Stewart, Robert
    Ghamande, Shekhar
    White, Heath
    Rasmussen, Jennifer
    Allen, Leigh
    CHEST, 2016, 150 (04) : 230A - 230A
  • [46] Continuous controlled-infusion of hypertonic saline solution in traumatic brain-injured patients: a 9-year retrospective study
    Antoine Roquilly
    Pierre Joachim Mahe
    Dominique Demeure Dit Latte
    Olivier Loutrel
    Philippe Champin
    Christelle Di Falco
    Athanase Courbe
    Kevin Buffenoir
    Olivier Hamel
    Corinne Lejus
    Véronique Sebille
    Karim Asehnoune
    Critical Care, 15
  • [47] Continuous Infusion of Hypertonic Saline vs Standard Care and 6-Month Neurological Outcomes in Patients With Traumatic Brain Injury Reply
    Roquilly, Antoine
    Asehnoune, Karim
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (15): : 1537 - 1538
  • [48] Continuous controlled-infusion of hypertonic saline solution in traumatic brain-injured patients: a 9-year retrospective study
    Roquilly, Antoine
    Mahe, Pierre Joachim
    Latte, Dominique Demeure Dit
    Loutrel, Olivier
    Champin, Philippe
    Di Falco, Christelle
    Courbe, Athanase
    Buffenoir, Kevin
    Hamel, Olivier
    Lejus, Corinne
    Sebille, Veronique
    Asehnoune, Karim
    CRITICAL CARE, 2011, 15 (05):
  • [49] Impact of Moderate Hyperchloremia on Clinical Outcomes in Intracerebral Hemorrhage Patients. Is There Still Room for Continuous Infusion of 3% Hypertonic Saline? reply
    Jones, G. Morgan
    Erdman, Michael J.
    Riha, Heidi M.
    CRITICAL CARE MEDICINE, 2018, 46 (02) : E179 - E179
  • [50] Hypertonic saline infusion: Can it regulate human neutrophil function?
    Angle, N
    Cabello-Passini, R
    Hoyt, DB
    Loomis, WH
    Shreve, A
    Namiki, S
    Junger, WG
    SHOCK, 2000, 14 (05): : 503 - 508